Nestlé Skin Health recently announced that the US Food and Drug Administration (FDA) has approved the hyaluronic acid (HA) dermal filler Restylane Lyft for the correction of age-related volume loss in the back of the hands for patients >21 years. Restylane Lyft is the first and only HA injectable gel to be FDA-approved for restoring fullness to the back of the hands providing more youthful-looking skin. It is also the first-ever HA dermal filler to receive FDA approval for an area other than the face.

HA is a natural occurring substance in the skin that helps provide fullness and elasticity. It diminishes with age, and causes the skin to lose volume, while increasing the chances for wrinkles to appear.

Adverse effects: The most commonly observed side effects are swelling, redness, pain, bruising, headache, tenderness, lump formation, itching at the injection site, and impaired hand function.